Sectors

CMRX
Chimerix, Inc.
8.54
undefined x undefined
undefined x undefined
bid
ask
-
0.01
0.12%
04:00 PM
timesize
Ytd145.40%
1y844.69%
8.54
day range
8.55
0.75
52 week range
8.55
Open8.52Prev Close8.55Low8.54High8.55Mkt Cap801.08M
Vol0.00Avg Vol4.05MEPS-0.99P/E-8.63Forward P/E-2.93
Beta-0.17Short Ratio2.44Inst. Own45.90%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg6.67200-d Avg2.751yr Est8.40

CMRX News

Jazz Pharmaceuticals Completes Acquisition of Chimerix
prnewswire.com
Jazz Pharmaceuticals Completes Acquisition of Chimerix

- Addition of dordaviprone strengthens Jazz's late-stage oncology pipeline and reinforces commitment

Biotech Stocks Q1 2025 Recap: Winners And Underperformers
seekingalpha.com
Biotech Stocks Q1 2025 Recap: Winners And Underperformers

Investing in biotech can be highly rewarding but is fraught with risks; understanding past catalysts

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
globenewswire.com
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results

New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma

CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX
businesswire.com
CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investig

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Mar

CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders
globenewswire.com
CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Sh

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
zacks.com
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Anal

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More
zacks.com
Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

CMRX and JAZZ are in the spotlight this week following an acquisition agreement.

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio
zacks.com
Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

JAZZ's acquisition of CMRX is set to add a rare high-grade brain tumor drug currently under the FDA'

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRX
prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRX

NEW YORK , March 5, 2025 /PRNewswire/ -- Monteverde & Associates PC  (the "M&A Class Action Firm"),

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders
prnewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders

NEW YORK , March 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investiga

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
benzinga.com
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline

On Tuesday, Jazz Pharmaceuticals plc JAZZ agreed to acquire Chimerix Inc CMRX for $8.55 per share in

Jazz Pharmaceuticals to buy Chimerix for $935 million
reuters.com
Jazz Pharmaceuticals to buy Chimerix for $935 million

Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million to gain access to its

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
prnewswire.com
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
globenewswire.com
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu

Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients
seekingalpha.com
Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients

The company holds potential to have first approval of dordaviprone for the treatment of recurrent H3

Here's Why Momentum in Chimerix (CMRX) Should Keep going
zacks.com
Here's Why Momentum in Chimerix (CMRX) Should Keep going

Chimerix (CMRX) made it through our "Recent Price Strength" screen and could be a great choice for i

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Febr

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know
zacks.com
CMRX Stock Skyrockets in 3 Months: Here's What You Should Know

Chimerix stock surges 324% in three months following NDA submission for high-grade glioma drug, dord

Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
globenewswire.com
Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium

DURHAM, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's trading, 1214 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For November 4, 2021

  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

  During Wednesday's morning trading, 254 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018

Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018

benzinga.com
Stocks Which Set New 52-Week Low Friday, October 26th

Stocks Which Set New 52-Week Low Friday, October 26th

benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 23rd

Stocks Which Set New 52-Week Low Yesterday, October 23rd